| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/28/2014 | US8637292 Polypeptides having feruloyl esterase activity and nucleic acids encoding the same |
| 01/28/2014 | US8637275 Postprandial hyperglycemia marker, method of measuring the same, and usage thereof |
| 01/28/2014 | US8637272 Halohydrin epoxidase |
| 01/28/2014 | US8637258 Compositions and methods for regulating NK cell activity |
| 01/28/2014 | US8637042 Targeted particles and methods of using the same |
| 01/28/2014 | US8637034 Pharmaceutical compositions comprising activated-potentiated antibodies to interferon-gamma and S100 protein |
| 01/28/2014 | US8637020 Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same and methods of use thereof |
| 01/28/2014 | US8637019 Engineered anti-TSLP antibody |
| 01/28/2014 | CA2581983C Plant promoters and uses thereof |
| 01/28/2014 | CA2534360C Methods for expression and purification of immunotoxins |
| 01/28/2014 | CA2520382C Lupus antibodies for passive immunotherapy of hiv/aids |
| 01/28/2014 | CA2510315C Antibodies against gpr64 and uses thereof |
| 01/28/2014 | CA2481799C Recombinant poxvirus expressing homologous genes inserted into the poxviral genome |
| 01/28/2014 | CA2438884C Enzymes having alpha amylase activity and methods of use thereof |
| 01/28/2014 | CA2430039C Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment |
| 01/25/2014 | CA2821384A1 Purification of cell culture derived alpha1 protease inhibitor |
| 01/23/2014 | WO2014015179A1 Carbohydrate esters as inducers for gene expression |
| 01/23/2014 | WO2014014086A1 Cancer detection method |
| 01/23/2014 | WO2014013538A1 Method for hydrolyzing plasmalogen, method for measuring plasmalogen, phospholipase-containing composition, and method for producing phospholipase |
| 01/23/2014 | WO2014013082A1 Method for the degradation of keratin and use of the keratin hydrolysate produced |
| 01/23/2014 | WO2014013081A2 Method |
| 01/23/2014 | WO2014013080A1 Method for the degradation of keratin and use of the keratin hydrolysate produced |
| 01/23/2014 | WO2014013074A1 Agse-deficient strain |
| 01/23/2014 | WO2014013073A1 Amylase-deficient strain |
| 01/23/2014 | WO2014013045A1 Filtration of cell culture supernatants |
| 01/23/2014 | WO2013184962A4 Chimeric fibroblast growth factor 19 proteins and methods of use |
| 01/23/2014 | WO2013181446A3 Metabolic therapy for oxidative stress in the brain through targeted neuronal catabolism of n-acetyl-aspartic acid |
| 01/23/2014 | WO2013170963A3 Enzymatic synthesis of l-nucleic acids |
| 01/23/2014 | US20140024812 Engineered intracellular sialylation pathways |
| 01/23/2014 | US20140024806 Glycoproteins Produced in Plants and Methods of Their Use |
| 01/23/2014 | US20140024079 Methods for producing biological materials |
| 01/23/2014 | US20140023637 Methods of Modifying Eukaryotic Cells |
| 01/23/2014 | US20140020694 Method for treating tobacco plants with enzymes |
| 01/23/2014 | CA2876287A1 Agse-deficient strain |
| 01/22/2014 | EP2687592A1 Filtration of cell culture supernatants |
| 01/22/2014 | EP2686426A1 Mutant cells for protein secretion and lignocellulose degradation |
| 01/22/2014 | EP2686335A2 Decorin compositions and use thereof |
| 01/22/2014 | CN203403039U Monomer reaction device for preparing gelatin by enzyme method |
| 01/22/2014 | CN103534355A Vectors conditionally expressing protein |
| 01/22/2014 | CN103534352A Method for selecting plasma cells and plasmablasts, method for producing target antigen-specific antibody, and new monoclonal antibody |
| 01/22/2014 | CN103534349A Polypeptides having endopeptidase activity and polynucleotides encoding same |
| 01/22/2014 | CN103534272A Antibody specifically recognising transferrin receptor |
| 01/22/2014 | CN103534271A Monoclonal antibody having immunosuppressive activity or fragment to which antigen thereof is bonded |
| 01/22/2014 | CN103534270A Human monoclonal antibody with specificity for dengue virus serotype 1 e protein and uses thereof |
| 01/22/2014 | CN103534269A Compositions and methods for the alteration of XLHED phenotypes |
| 01/22/2014 | CN103534268A Antibodies |
| 01/22/2014 | CN103533957A Humanized antibodies to LIV-1 and use of same to treat cancer |
| 01/22/2014 | CN103525894A Preparation method and application of bacillus and lactobacillus composite antimicrobial peptides |
| 01/22/2014 | CN103525891A Preparation method for chickpea antibacterial peptides |
| 01/22/2014 | CN103525890A Preparation method of human placenta collagen |
| 01/22/2014 | CN103525889A Synthetic method for Cilengitide by using thioesterase |
| 01/22/2014 | CN103525847A Novel aldolases and process for producing substituted alpha-keto acid |
| 01/22/2014 | CN103525747A Polyoxin B high-producing strain and preparation method thereof |
| 01/22/2014 | CN103524610A Anti-freezing polypeptide and preparation method thereof |
| 01/22/2014 | CN103524600A New cyclic lipopeptides locillomycin A, B and C and preparation method thereof |
| 01/22/2014 | CN103524597A Antioxidant peptide prepared from shark prolamin and preparation method and application thereof |
| 01/22/2014 | CN103524596A Antioxidative peptide of shark protein as well as preparation method and use thereof |
| 01/21/2014 | US8633301 Antitumor combinations containing antibodies recognizing specifically CD38 and vincristine |
| 01/21/2014 | US8633164 Antimicrobial peptides |
| 01/21/2014 | US8632996 Method for producing recombinant antibody and antibody fragment thereof |
| 01/21/2014 | US8632995 High-cell density fed-batch fermentation process for producing recombinant protein |
| 01/21/2014 | US8632993 Method for grass species identification |
| 01/21/2014 | US8632779 S. aureus polypeptides and antibodies |
| 01/21/2014 | US8632778 Stabilized anti-interleukin-6 antibody-containing preparations |
| 01/21/2014 | CA2665748C Immunogenic peptide composition for the prevention and treatment of alzheimer's disease |
| 01/21/2014 | CA2595115C Fusion proteins for treating, preventing or ameliorating pain |
| 01/21/2014 | CA2546083C Novel brevibacillus choshinensis and method for producing protein using the microorganism as host |
| 01/21/2014 | CA2495177C Novel n-acetylgalactosamine transferases and nucleic acids encoding the same |
| 01/21/2014 | CA2388477C Recombinant gelatins with uniform molecular weight |
| 01/21/2014 | CA2341763C Antigenic peptides of aglyco 10b and antibodies thereto |
| 01/16/2014 | WO2014011723A1 Generation of native recombinant secreted human endoplasmic reticulum chaperones by using their native signal sequences in yeast expression systems |
| 01/16/2014 | WO2014011662A2 Acid stable prolyl endopeptidases for degrading gluten |
| 01/16/2014 | WO2014010619A1 Method for introducing fluorine into peptide or protein |
| 01/16/2014 | WO2014009515A1 Method for producing a recombinant protein of interest |
| 01/16/2014 | WO2013177231A8 Translocation of non-natural chemical entities through anthrax protective antigen pore |
| 01/16/2014 | US20140020125 Methods of Modifying Eukaryotic Cells |
| 01/16/2014 | US20140020124 Methods of Modifying Eukaryotic Cells |
| 01/16/2014 | US20140018522 Methods of Modifying Eukaryotic Cells |
| 01/16/2014 | US20140017782 Methods for Modifying Eukaryotic Cells |
| 01/16/2014 | US20140017781 Methods of Modifying Eukaryotic Cells |
| 01/16/2014 | US20140017774 Pca3, pca3 genes, and methods of use |
| 01/16/2014 | US20140017725 Methods of Making Nanotechnological and Macromolecular Biomimetic Structures |
| 01/16/2014 | US20140017274 Method for the production of protein complexes and vaccine compositions comprising the same |
| 01/16/2014 | US20140017273 Albumin-Fused Anti-Angiogenesis Peptides |
| 01/16/2014 | US20140017238 Methods of Modifying Eukaryotic Cells |
| 01/16/2014 | US20140017229 Methods of Modifying Eukaryotic Cells |
| 01/15/2014 | EP2684952A1 Azoline compound and azole compound library and method for producing same |
| 01/15/2014 | EP2684951A1 Method for producing a recombinant protein of interest |
| 01/15/2014 | EP2684948A1 Method for producing heterologous protein using yeast having knocked out vps gene |
| 01/15/2014 | EP2684890A1 Methods of intracellular conversion of single-chain proteins into their di-chain form |
| 01/15/2014 | EP2684889A2 Multivariable antigens complexed with targeting humanized monoclonal antibody |
| 01/15/2014 | EP1037926B1 TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 01/15/2014 | CN103509841A Production technology for transforming cordyceps militaris waste residue and scrap into antioxidant peptide functional factor |
| 01/15/2014 | CN103509840A Method for increasing yield of anidulafungin precursor compound Echinocandin B |
| 01/15/2014 | CN103509839A Method for reducing ammonia nitrogen content in polymyxin E fermentation liquor |
| 01/15/2014 | CN103509838A High expression production process and extraction method of piglet escherichia coli K88, K99 and 987P cilium antigens |
| 01/15/2014 | CN103509823A Eukaryotic expression vector for producing recombinant protein by using CHO cells, and system |
| 01/15/2014 | CN103509808A Insecticidal gene and applications thereof |
| 01/15/2014 | CN103509779A Protein glnrps4 involved in pneumocandin synthesis, and its coding gene |
| 01/15/2014 | CN103509739A Bacillus licheniformis producing multiple enzyme systems, and preparation method and application thereof |